Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A Phase 3, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Bosutinib in Patients With Chronic myeloid leukemia / Chronic myelogenous leukemia (CML) in Chronic Phase (CML-CP), Previously Treated With 2 or More Tyrosine Kinase Inhibitors
Primary outcome measures:
Number of Participants With Major Molecular Response (MMR) Rate at 24 Weeks…